Explore every episode of the podcast The Lancet Respiratory Medicine in conversation with
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest | 22 Dec 2025 | 00:07:52 | |
Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment. Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext Continue this conversation on social! | |||
| Sailesh Kotecha on Prematurity-associated lung disease | 27 Nov 2025 | 00:11:29 | |
Prof Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birth and evolves throughout life. Cick here to read the full series: Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes Trajectories of prematurity-associated lung disease: lifelong lung health Management of prematurity-associated lung disease from infancy through to adulthood Continue this conversation on social! | |||
| Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS | 04 Jun 2025 | 00:11:51 | |
Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping ARDS. The findings underscore the need to refine the ARDS definition to better address heterogeneity of the condition and improve diagnostic precision, with use of subphenotyping where appropriate. Read the full article: Continue this conversation on social! | |||
| Hjalmar Bouma on sepsis in patients who are immunocompromised | 20 May 2025 | 00:13:33 | |
Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies. The episode also analyses the increased vulnerability of specific patient groups, the importance of biomarker-driven personalised medicine, and the need for improved representation of immunosuppressed patients in clinical trials. Read the full article: Continue this conversation on social! | |||
| Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019 | 07 Apr 2025 | 00:11:47 | |
Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich. This episode delves into the prevalence, risk factors, and clinical implications of this rare but serious condition, highlighting the need for increased awareness and further research. Read the full article: Continue this conversation on social! | |||
| Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension | 19 Feb 2025 | 00:14:53 | |
Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension. Read the full paper, Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients, here: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00425-9/fulltext Continue this conversation on social! | |||
| Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian) | 25 Oct 2024 | 00:10:40 | |
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM). Continue this conversation on social! | |||
| Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM) | 25 Oct 2024 | 00:10:26 | |
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM). Continue this conversation on social! | |||
| Robert Kullberg on empirical antibiotics for Sepsis | 11 Oct 2024 | 00:12:06 | |
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics. Continue this conversation on social! | |||
| Heather Zar on early-life RSV disease and long-term respiratory health | 09 Sep 2024 | 00:19:07 | |
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet. Continue this conversation on social! | |||
| Margaux Mesle on lives saved by COVID-19 vaccination | 07 Aug 2024 | 00:10:21 | |
Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications. Continue this conversation on social! | |||
| James Hull on protecting the respiratory health of athletes | 25 Jul 2024 | 00:11:04 | |
Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics. Continue this conversation on social! | |||
| Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations | 25 Nov 2025 | 00:15:25 | |
Dr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations. click here to read the full article: Continue this conversation on social! | |||
| Eric Lim on treatments for pleural mesothelioma | 10 May 2024 | 00:06:17 | |
Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma. Continue this conversation on social! | |||
| Anne Chang on the burden of chronic respiratory diseases in Indigenous people | 24 Apr 2024 | 00:09:49 | |
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people. Continue this conversation on social! | |||
| Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC | 12 Mar 2024 | 00:10:23 | |
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer. Continue this conversation on social! | |||
| Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID | 16 Jan 2024 | 00:08:16 | |
Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2. Continue this conversation on social! | |||
| Sarah Gorst and Tim Nicholson on long COVID outcomes | 02 Nov 2023 | 00:15:32 | |
Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care. Continue this conversation on social! | |||
| Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 | 04 Oct 2023 | 00:12:02 | |
Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19. Continue this conversation on social! | |||
| Keith Chappell on a bivalent recombinant vaccine for COVID-19 | 13 Sep 2023 | 00:08:13 | |
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials. Continue this conversation on social! | |||
| James Chalmers on bronchiectasis across Europe | 26 Apr 2023 | 00:11:57 | |
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry. Continue this conversation on social! | |||
| Richard Costello on management of uncontrolled asthma | 21 Mar 2023 | 00:11:38 | |
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma. Continue this conversation on social! | |||
| Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer | 06 Mar 2023 | 00:05:51 | |
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less. Continue this conversation on social! | |||
| Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change | 30 Oct 2025 | 00:10:50 | |
Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis. Click here to read the full article Continue this conversation on social! | |||
| Carol Hodgson on post-discharge outcomes for ECMO patients | 09 Feb 2023 | 00:19:16 | |
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO. Continue this conversation on social! | |||
| Emma Grainger on 10 years of The Lancet Respiratory Medicine | 22 Dec 2022 | 00:13:06 | |
Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal. Continue this conversation on social! | |||
| Vivienne Kahlmann and Catharina Moor on the TIRED study | 23 Nov 2022 | 00:09:00 | |
Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis. Continue this conversation on social! | |||
| Yves Lacasse on long-term oxygen therapy for COPD | 31 Jul 2022 | 00:17:15 | |
Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD. Continue this conversation on social! | |||
| Rachael Evans on living with long COVID | 26 Jul 2022 | 00:13:28 | |
Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study. Continue this conversation on social! | |||
| Daniel Munblit and Dale Needham on core outcomes post-COVID-19 | 15 Jun 2022 | 00:16:37 | |
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition. Continue this conversation on social! | |||
| Daiana Stolz on antibiotic stewardship in pneumonia | 24 May 2022 | 00:10:16 | |
Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection. Continue this conversation on social! | |||
| Ablo Wachinou on sleep disordered breathing in Benin | 08 Apr 2022 | 00:10:39 | |
Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved. Continue this conversation on social! | |||
| Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID | 07 Apr 2022 | 00:14:46 | |
Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection. Continue this conversation on social! | |||
| Dinh Bui on preterm birth and lung function deficits | 18 Feb 2022 | 00:05:31 | |
Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53. Continue this conversation on social! | |||
| Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis | 28 Sep 2025 | 00:09:26 | |
Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis. Read the full article: Continue this conversation on social! | |||
| Ruvim Izĭckson on a joint flu and COVID-19 vaccine | 31 Jan 2022 | 00:08:41 | |
Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older. Continue this conversation on social! | |||
| Wisia Wedzicha on a vaccine for COPD | 11 Jan 2022 | 00:09:05 | |
Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research. Continue this conversation on social! | |||
| Eileen Rubin on patient-centered ARDS | 30 Dec 2021 | 00:17:05 | |
Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients. Continue this conversation on social! | |||
| Daniel Altmann on COVID boosters | 30 Nov 2021 | 00:16:11 | |
Daniel Atlmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes. Continue this conversation on social! | |||
| Michael Kreuter on interstitial lung disease | 06 Sep 2021 | 00:08:28 | |
Comment author Michael Kreuter discusses a series of papers published in The Lancet and The Lancet Respiratory Medicine on interstitial lung disease. Continue this conversation on social! | |||
| Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 | 20 Aug 2021 | 00:12:04 | |
Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.
Continue this conversation on social! | |||
| Charles Sprung and authors on end-of-life practices in ICUs globally | 03 Aug 2021 | 00:15:41 | |
Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries. Continue this conversation on social! | |||
| Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma | 10 Jul 2021 | 00:13:17 | |
Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma. Continue this conversation on social! | |||
| Paul Verweij on COVID-19 associated aspergillosis | 26 May 2021 | 00:06:36 | |
Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis. Continue this conversation on social! | |||
| Ignacio Rubio on COVID-19 pathophysiology and phenotypes | 17 May 2021 | 00:09:19 | |
Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease. Continue this conversation on social! | |||
| Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma | 28 Sep 2025 | 00:22:43 | |
Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on asthma at ERS in Amsterdam. The Series aims to provide an overview of recent research advances related to asthma; to provide new insights into the genetics, prevention and risk factors for asthma; review advances arising as a result of the use of monoclonal antibody therapeutics; and assess remission in adult patients. Late breaking research will also be included within the journal session and linked to the Series. Read the full Series: https://www.thelancet.com/series-do/asthma-2025?dgcid=buzzsprout_icw_podcast_asthma25_lanres Continue this conversation on social! | |||
| Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia | 14 May 2021 | 00:09:54 | |
Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia. Continue this conversation on social! | |||
| Fan Chung on chronic cough and long COVID | 11 May 2021 | 00:11:32 | |
Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome. Continue this conversation on social! | |||
| Mepolizumab and the treatment of chronic rhinosinusitis | 16 Apr 2021 | 00:07:18 | |
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis. Continue this conversation on social! | |||
| Inhaled budesonide in the treatment of early COVID-19 | 15 Apr 2021 | 00:10:24 | |
Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19. Continue this conversation on social! | |||